Key Findings:  This review summarizes evidence that cannabidiol (CBD) exerts therapeutic effects on the gastrointestinal system by modulating intestinal permeability, the microbiome, immune responses, and cytokines, suggesting potential benefits for treating gastrointestinal disorders like inflammatory bowel disease (IBD) as well as other conditions such as non-alcoholic liver disease and epilepsy.
Type of Study:  Meta-analysis
Study Result:  Positive
Research Location(s):  United States
Year of Pub:  2024
Cannabinoids Studied:  Cannabidiol (CBD), Microbiome
Phytocannabinoid Source:  Unspecified
Route of Administration:  Oral (Ingestion)
Citation:  Brown K, et al. The Modulatory Effects and Therapeutic Potential of Cannabidiol in the Gut. Cells. 2024; 13:(unknown pages). doi: 10.3390/cells13191618
Authors:  Brown K, Funk K, Figueroa Barrientos A, Bailey A, Shrader S, Feng W, McClain CJ, Song ZH